Norgine Ventures Overview
Founded in 2012, Norgine Ventures is a venture capital firm based in Uxbridge, United Kingdom. It offers debt and debt-like financing to innovative, fast-growing companies in the healthcare and life sciences sectors across Europe and the United States. Backed by Norgine, a European specialty pharmaceutical company with over 100 years of experience, Norgine Ventures leverages its parent company's technical capabilities to evaluate investment opportunities, aiming for financial returns rather than strategic interests.
Is Norgine Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Norgine Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
Norgine Ventures
Investment focus
Product type
- Software
- Hardware
- Services
- Drugs / Pharma
- Other
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- Health Data, Healthcare Systems & Infrastructure
- MedTech & Devices
Stages
Series A, Series B or later
First ticket size
€5,000,000 - €15,000,000
How to approach funds like Norgine Ventures
When approaching Norgine Ventures, founders should highlight robust revenue streams, clear paths to profitability, and strong market traction, as the firm favors companies with proven business models and significant growth potential. Emphasize how your solution addresses unmet needs in healthcare or life sciences, and be prepared to discuss how non-dilutive capital will accelerate your commercial milestones. Demonstrating a disciplined use of funds and a credible plan for scaling within regulated markets will resonate with their risk-conscious, growth-oriented approach.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
